Self-care strategist in older adults with prostate cancer in the community
Keywords:
DeCs, CÁNCER DE PRÓSTATA, AUTOCUIDADO, SOBREVIDA, ESTADO DE SALUD.Abstract
Background: prostate cancer is the second most common type of cancer in men. However, many men who develop prostate cancer never have symptoms, nor they undergo therapy. Several factors, including genetics and diet, have been implicated in its development; the known primary prevention modalities are insufficient to eliminate the risk of contracting the disease.
Objective: to propose a self-care strategy in the elderly with prostate cancer in the community.
Methods: intervention and development study in the Polyclinic Center of the Municipality and Province of Sancti Spíritus, from 2016 to 2017. Study variables were level of knowledge of physicians, self-care, health status, survival. Structured interview was used to elderly people with prostate cancer in the community to know the improvement of health status, after applying the strategy population proportions were compared by McNemar test.
Results: significant changes were achieved in the level of knowledge of physicians, at the end of the training program it was obtained a 56.52 % which shows an acceptable level. 61,53 % of the health status of the elderly was good; self-care was reached in an acceptable manner in 63.46 %. The survival with more than ten years after applying the strategy was 67.30 %.
Conclusions: the self-care strategy was achieved in older adults with prostate cancer, which includes actions and activities that favor the achievement of significant changes in self-care.
DeCS: PROSTATIC NEOPLASMS; AGED; SELF CARE; HEALTH STATUS; CLINICAL TRIAL.
Downloads
References
1. Toledo Valdés C, Pacheco Macías AR, Pérez García T, Contreras Álvarez PJ, Hernández Armstrong L. Características clínico-epidemiológicas de pacientes ancianos con Hipoacusia atendidos en el Hospital Calixto García. Rev haban cienc méd [Internet]. 2018 [citado 17 Abr 2019];17(3):[aprox. 12 p.]. Disponible en: http://www.revhabanera.sld.cu/index.php/rhab/article/view/2152
2. Baró Bouly T, Fernández Hernández M, Milanés Gonzáles T, Morlote Castañeda Y, Duany Rodríguez L. Acciones educativas para mejorar la calidad de vida en adultos mayores. Rev inf cient [Internet]. 2017 [citado 17 Abr 2019];96(5):[aprox. 7 p.]. Disponible en: http://www.revinfcientifica.sld.cu/index.php/ric/article/view/1739
3. Ruiz López AI, Pérez Mesa JC, Cruz Batista Y, González Lorenzo LE. Actualización sobre cáncer de próstata. CCM [Internet]. Sep 2017 [citado 19 Nov 2018];21(3):[aprox. 12 p.]. Disponible en: http://scielo.sld.cu/scielo.php?script=sci_arttext&pid=S1560-43812017000300021&lng=es
4. González Fernández RS, Martínez Ramos JB, del Valle García R, Cazanave Mora J, Legrá Torres ME. Uso del UMELISA PSA en la pesquisa de cáncer de próstata en Cuba. Rev Cubana Urol [Internet]. 2018 [citado 19 Nov 2018];7(No Esp):[aprox. 1 p.]. Disponible en: http://www.revurologia.sld.cu/index.php/rcu/article/view/408
5. Fernández Marichal FS, Toirán García Rl, Varela Álvarez A, Segura Roque O. Cáncer prostático: correlación entre el valor del antígeno prostático específico y el resultado anatomoclínico. Arch Med Camagüey [Internet]. Feb 2015 [citado 19 Nov 2018];19(1):[aprox. 8 p.]. Disponible en: http://scielo.sld.cu/scielo.php?script=sci_arttext&pid=S1025-02552015000100008&lng=es
6. Moraga Rodríguez A, Zamora Matamoros L, Sagaró del Campo NM, Moraga Rodríguez A, Rodríguez Griñán A. Análisis estadístico implicativo para la identificación de factores pronósticos de la mortalidad por cáncer de próstata. MEDISAN [Internet]. Ene 2018 [citado 19 Nov 2018];22(1):[aprox. 9 p.]. Disponible en: http://scielo.sld.cu/scielo.php?script=sci_arttext&pid=S1029-30192018000100007&lng=es
7. Sagué Larrea JL, Franco Camejo L, Doimeadios Rodríguez Z. Propuesta de un plan de acción para reducir la mortalidad por cáncer de próstata en Holguín. CCM [Internet]. Mar 2017 [citado 08 Jun 2019];21(1):[aprox. 11 p.]. Disponible en: http://scielo.sld.cu/scielo.php?script=sci_arttext&pid=S1560-43812017000100018&lng=es
8. Luna Acalá A, Vilanova JC, Alcalá Mata L. RM de cuerpo entero en la detección precoz de las metástasis óseas y su indicación frente a la gammagrafia ósea y otras técnicas de imagen. Arch Esp Urol [Internet]. 2015 [citado 8 Jun 2019];68(3):[aprox. 19 p.]. Disponible en: http://aeurologia.com/articulo_prod.php?id_art=2955992838635
9. Escalona Veloz R, Estrada Mateo NR. Demostración histoquímica de mucina para el diagnóstico diferencial de las lesiones benignas y malignas de próstata. MEDISAN [Internet]. Abr 2017 [citado 26 May 2017];21(4):[aprox. 7 p]. Disponible en: http://scieloprueba.sld.cu/scielo.php?script=sci_arttext&pid=S1029-30192017000400002&lng=es
10. Valiente Morejón W, Junco Sena B, Padrón Vega Y, Ramos Águila Y, Castillo García I. Antígeno prostático específico como predictor del diagnóstico de adenocarcinoma prostático. Rev Finlay [Internet]. Dic 2015 [citado 19 Nov 2018];5(4):[aprox. 7 p.]. Disponible en: http://scielo.sld.cu/scielo.php?script=sci_arttext&pid=S2221-24342015000400002&lng=es
11. Pérez García K, Ronquillo Paneca B, Coronel Carbajal C, Abreu Viamontes C. Intervención educativa sobre cáncer de próstata en población masculina entre 40 a 60 años. Arch Med Camagüey [Internet]. Feb 2018 [citado 19 Nov 2018];22(1):[aprox. 8 p.]. Disponible en: http://scielo.sld.cu/scielo.php?script=sci_arttext&pid=S1025-02552018000100004&lng=es
12. Cortés Cardona CM, Mejia Luis FF. Caracterización Sociodemográfica y Patológica del Cáncer de Próstata, Hospital Escuela Universitario e Instituto Hondureño Seguridad Social, Tegucigalpa, Honduras. Arch Med Manizales [Internet]. Abr 2017 [citado 26 Dic 2017];13(2):[aprox. 4 p.]. Disponible en: http://www.archivosdemedicina.com/medicina-de-familia/caracterizacioacuten-sociodemograacutefica-y-patoloacutegica-del-caacutencer-de-proacutestata-hospital-escuela-universitario-e-ins.pdf
13. Sagué Larrea Jl, Franco Camejo L, Doimeadios Rodríguez Z. Propuesta de un plan de acción para reducir la mortalidad por cáncer de próstata en Holguín. CCM [Internet]. Mar 2017 [citado 26 May 2017];21(1):[aprox. 8 p]. Disponible en: http://scieloprueba.sld.cu/scielo.php?script=sci_arttext&pid=S1560-43812017000100018&lng=es
14. Bacelar Junior AJ, Menezes CS, Barbosa CA, Silva Freitas GB, Gonçalves Silva G, Sousa Vaz JP. Câncer de próstata: métodos de diagnóstico, prevenção e tratamento. Braz J Surg Clin Res [Internet]. 2015 [citado 21 Jun 2016];10(3):[aprox. 7 p.]. Disponible en: http://www.mastereditora.com.br/bjscr/periodico/20150501_174533.pdf
15. Kupka da Silva R, Dall'oglio MF, Crippa Sant'ana A, Pontes Júnior J, Srougi M. Can Single Positive Core Prostate Cancer at biopsy be Considered a Low-Risk Disease after Radical Prostatecto-my? Int Braz J Urol. 2013 Dec;39(6):12-4.
16. Katelaris N, Murphy D, Lawrentschuk N, Katelaris A, Moon D. Cytoreductive surgery for men with metastatic prostate cancer. Prostate Int [Internet]. 2016 [citado 17 Jun 2019];4(3): [aprox. 13 p.]. Disponible en: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5031896/.
Published
How to Cite
Issue
Section
License
Copyright: Camagüey Medical Archive Magazine, offers immediately after being indexed in the SciELO Project; Open access to the full text of the articles under the principle of making available and free the research to promote the exchange of global knowledge and contribute to a greater extension, publication, evaluation and extensive use of the articles that can be used without purpose As long as reference is made to the primary source.
Conflicts of interest: authors must declare in a mandatory manner the presence or not of conflicts of interest in relation to the investigation presented.
(Download Statement of potential conflicts of interest)
The Revista Archivo Médico de Camagüey is under a License Creative Commons Attribution-Noncommercial-No Derivative Works 4.0 International (CC BY 4.0).
This license allows others to distribute, to mix, to adjust and to build from its work, even for commercial purposes, as long as it is recognized the authorship of the original creation. This is the most helpful license offered. Recommended for maximum dissemination and use of licensed materials. The full license can be found at: https://creativecommons.org/licenses/
22 julio 2025